A detailed history of Geode Capital Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,413,215 shares of MRSN stock, worth $6.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,413,215
Previous 2,493,423 3.22%
Holding current value
$6.11 Million
Previous $5.01 Million 9.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.23 - $2.25 $98,655 - $180,468
-80,208 Reduced 3.22%
2,413,215 $4.56 Million
Q2 2024

Aug 09, 2024

BUY
$2.0 - $4.45 $270,404 - $601,648
135,202 Added 5.73%
2,493,423 $5.01 Million
Q1 2024

May 13, 2024

BUY
$2.16 - $5.94 $131,943 - $362,844
61,085 Added 2.66%
2,358,221 $10.6 Million
Q4 2023

Feb 13, 2024

BUY
$1.11 - $2.34 $154,812 - $326,362
139,471 Added 6.46%
2,297,136 $5.33 Million
Q3 2023

Nov 13, 2023

BUY
$1.06 - $3.91 $161,101 - $594,253
151,983 Added 7.58%
2,157,665 $2.74 Million
Q2 2023

Aug 11, 2023

BUY
$3.08 - $9.55 $637,051 - $1.98 Million
206,835 Added 11.5%
2,005,682 $6.6 Million
Q1 2023

May 15, 2023

BUY
$4.0 - $7.02 $365,508 - $641,466
91,377 Added 5.35%
1,798,847 $7.39 Million
Q4 2022

Feb 13, 2023

BUY
$5.65 - $7.86 $324,598 - $451,564
57,451 Added 3.48%
1,707,470 $10 Million
Q3 2022

Nov 14, 2022

BUY
$4.63 - $8.0 $361,505 - $624,632
78,079 Added 4.97%
1,650,019 $11.2 Million
Q2 2022

Aug 12, 2022

BUY
$2.84 - $5.0 $1.15 Million - $2.03 Million
405,133 Added 34.72%
1,571,940 $7.26 Million
Q1 2022

May 13, 2022

BUY
$3.74 - $6.63 $111,474 - $197,613
29,806 Added 2.62%
1,166,807 $4.66 Million
Q4 2021

Feb 11, 2022

BUY
$5.48 - $9.86 $398,209 - $716,486
72,666 Added 6.83%
1,137,001 $7.07 Million
Q3 2021

Nov 12, 2021

BUY
$8.56 - $14.47 $106,280 - $179,659
12,416 Added 1.18%
1,064,335 $10 Million
Q2 2021

Aug 13, 2021

BUY
$13.28 - $18.07 $1.25 Million - $1.7 Million
93,868 Added 9.8%
1,051,919 $14.3 Million
Q1 2021

May 12, 2021

BUY
$15.31 - $26.52 $1.51 Million - $2.62 Million
98,750 Added 11.49%
958,051 $15.5 Million
Q4 2020

Feb 12, 2021

BUY
$16.84 - $27.59 $510,673 - $836,666
30,325 Added 3.66%
859,301 $22.9 Million
Q3 2020

Nov 13, 2020

BUY
$16.2 - $25.7 $1.1 Million - $1.74 Million
67,724 Added 8.9%
828,976 $15.4 Million
Q2 2020

Aug 13, 2020

BUY
$5.24 - $23.4 $1.21 Million - $5.42 Million
231,464 Added 43.69%
761,252 $17.8 Million
Q1 2020

May 14, 2020

BUY
$4.41 - $9.28 $2,716 - $5,716
616 Added 0.12%
529,788 $3.09 Million
Q4 2019

Feb 13, 2020

BUY
$1.45 - $6.73 $64,902 - $301,234
44,760 Added 9.24%
529,172 $3.03 Million
Q3 2019

Nov 12, 2019

BUY
$1.54 - $4.2 $1,841 - $5,023
1,196 Added 0.25%
484,412 $765,000
Q2 2019

Aug 14, 2019

BUY
$3.84 - $6.4 $436,051 - $726,752
113,555 Added 30.72%
483,216 $1.96 Million
Q1 2019

May 14, 2019

BUY
$3.51 - $7.3 $847,415 - $1.76 Million
241,429 Added 188.28%
369,661 $1.94 Million
Q4 2018

Feb 13, 2019

BUY
$3.45 - $9.72 $20,003 - $56,356
5,798 Added 4.74%
128,232 $523,000
Q3 2018

Nov 13, 2018

BUY
$10.0 - $19.02 $315,250 - $599,605
31,525 Added 34.68%
122,434 $1.22 Million
Q2 2018

Aug 14, 2018

BUY
$14.2 - $22.68 $66,626 - $106,414
4,692 Added 5.44%
90,909 $1.62 Million
Q1 2018

May 15, 2018

BUY
$13.56 - $18.48 $312,476 - $425,853
23,044 Added 36.48%
86,217 $1.36 Million
Q4 2017

Feb 13, 2018

BUY
$14.95 - $19.9 $87,023 - $115,837
5,821 Added 10.15%
63,173 $1.04 Million
Q3 2017

Nov 14, 2017

BUY
$14.8 - $18.06 $848,809 - $1.04 Million
57,352
57,352 $991,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $246M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.